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Mitochondrial DNA (mtDNA) mutations are a major cause of human disease. A large number of differentmolecular
defects ultimately compromise oxidative phosphorylation, but it is not clear why the same biochemical defect can
cause diverse clinical phenotypes. There is emerging evidence that nuclear genes modulate the phenotype of primary
mtDNA disorders. Here, we deﬁne an X-chromosomal haplotype that interacts with speciﬁc MTND mutations to
cause visual failure in the most common mtDNA disease, Leber hereditary optic neuropathy. This effect is inde-
pendent of the mtDNA genetic background and explains the variable penetrance and sex bias that characterizes
this disorder.
Leber hereditary optic neuropathy (LHON [MIM
535000]) typically presents in young adult life with se-
quential bilateral visual failure due to focal degeneration
of retinal ganglion cells within the optic nerve (Nikos-
kelainen et al. 1996; Howell 1997). In 95% of cases
worldwide, LHON is due to one of three point muta-
tions of mtDNA in genes that code for complex I of the
respiratory chain: 3460GrA in MTND1, 11778GrA in
MTND4, and 14484TrC in MTND6 (Mackey et al.
1996). Only ∼50% of male and ∼10% of female mu-
tation carriers develop symptoms, which indicates that
additional genetic or environmental factors are required
for the phenotypic expression of LHON (Newman
2002). Epidemiological studies have failed to substan-
tiate anecdotal reports of a link with excess alcohol and
tobacco (Kerrison et al. 2000), but segregation analyses
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are consistent with a nuclear-encoded X-linked suscep-
tibility allele in some pedigrees (Bu and Rotter 1991;
Nakamura et al. 1993). Early attempts to map the locus
were inconclusive (Chen et al. 1989; Vilkki et al. 1991;
Carvalho et al. 1992), but these studies used widely
spaced, often noninformative markers and failed to ac-
count for mtDNA heteroplasmy, which can inﬂuence the
expression of LHON. Later studies were more compre-
hensive, but exclusion mapping was based on an X-
linked recessive model, which cannot explain the seg-
regation pattern in all pedigrees (Mackey 1993), and
study size limited the power to exclude a substantial
portion of the X chromosome (Juvonen et al. 1993;
Chalmers et al. 1996).
LHONmutations are found in ∼1 in 8,500 individuals
in the general population and are inherited through the
maternal line (Man et al. 2003). Large multigenerational
pedigrees with LHON are well recognized, with affected
individuals present in 10 generations. It is therefore
unlikely that a nuclear modiﬁer locus would be strictly
coinherited with the primary mtDNAmutation through-
out the whole pedigree. Given the relative rarity of the
primary mtDNA mutation, it is far more likely that
the nuclear modiﬁer is common in the general popula-
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Table 1
Frequency of the DXS8090(166)-DXS1068(258) Haplotype in European Males with Different Primary LHON mtDNA




Pa OR (95% CI)bUnaffected Affected
3460ArG:
Non DXS8090(166)-DXS1068(258) 7 8 .66 1.75 (.24–12.64)
DXS8090(166)-DXS1068(258) 2 4
Non 3460ArG:
Non DXS8090(166)-DXS1068(258) 47 44 !.0001 35.25 (4.62–268.80)
DXS8090(166)-DXS1068(258) 1 33
NOTE.—14495ArG has been described in two families with LHON, and, like 14484TrC, it affects the MTND6 gene
and is associated with a good prognosis (Chinnery et al. 2001b). The single 14495ArG family was pooled with the other
non-3460ArG LHON pedigrees, because of the limited number of 14484TrC and 14495ArG pedigrees. Although it
is possible that limited power explains the lack of association between DXS8090(166)-DXS1068(258) and visual failure
in 3460ArG males, the increased penetrance of LHON in 3460ArG families (in this study, 62% of males and 29% of
females are affected) suggests that a nuclear modiﬁer locus is less inﬂuential in this subgroup.
a Fisher’s exact P.
b Corresponding to the risk of visual failure.
tion and moves in and out of the maternal pedigree
through random mating between mothers who transmit
the LHON mtDNA mutation (who largely remain un-
affected) and unrelated male partners not harboring the
LHON mtDNA mutation. The nuclear modiﬁer is there-
fore likely to be one or more ancient genetic variants
that may be present at a high frequency in the popu-
lation. We therefore used a nonparametric complex-dis-
ease-mapping strategy to identify the locus.
A total of 389 DNA samples were collected from af-
fected and unaffected individuals from 100 families with
LHON (6 families from Finland, 23 from the United
Kingdom, 54 from Italy, 15 fromHungary, 1 from Spain,
and 1 from Slovenia). The clinical phenotype was de-
termined by local ophthalmologists. Affected individuals
had the characteristic phenotype of LHON, presenting
with acute or subacute painless sequential or bilateral
visual failure in the presence of an established pathogenic
mtDNA mutation, with no other inﬂammatory, meta-
bolic, or structural cause identiﬁed. Unaffected individ-
uals had no visual symptoms and were older than the
median age at onset for LHON (24 years). The diagnosis
in affected individuals was conﬁrmed by direct sequenc-
ing of the MTND genes or by PCR-RFLP analysis. The
percentage with heteroplasmy was determined by ﬂuo-
rescent primer-extension assay (Man et al. 2003). Only
samples with 170% mutated mtDNA were included in
the linkage study, because this level of mutated mtDNA
is associated with the same penetrance as homoplasmic
mutated mtDNA (Chinnery et al. 2001a). Subjects were
homoplasmic for the following primary LHON mtDNA
mutations: 11778GrA ( subjects; 51% male),np 290
14484TrC ( ; 61% male), 3460ArG ( ;np 18 np 75
49% male), and 14495ArG ( ; 50% male).np 6
Linkage disequilibrium (LD) blocks in young, geo-
graphically isolated populations are generally larger than
average, which facilitates low-density linkage mapping
of complex traits (Wright et al. 1999). We therefore ini-
tially performed nonparametric linkage (NPL) analysis
in six Finnish families. X-chromosome microsatellite
analysis was performed using part of the 9-cM Weber
human genome screening set (version 10aRG [Invitro-
gen]) in accordance with the manufacturer’s conditions,
and markers were sized using a Beckman Coulter CEQ
8000 ﬂuorescent DNA analyzer. NPL analysis was per-
formed using Genehunter, version 1.3. Markers between
DXS9896 and DXS9893 had multipoint NPL scores 12,
identifying a region with a maximal NPL score of 10.2
(DXS1068 in ﬁg. 1a). The region was mapped further
with 12 additional markers identiﬁed from the UniSTS
database, synthesized with a forward ﬂuorescent tag
(Proligo), and sized using the same method. Fine map-
ping conﬁrmed our ﬁndings, with an NPL score 145
spanning 1 cM for markers DXS8090, DXS8376, and
DXS7487 (ﬁg. 1b).
The X-linked reconstruction-combination transmis-
sion/disequilibrium test (XRC-TDT) (Horvath et al.
2000) with the use of informative markers conﬁrmed
that 2.4 Mb of the X chromosome ﬂanked by DXS8090
and DXS8016 was being preferentially transmitted to
affected male offspring in the Finnish families (ﬁg. 1c).
We then turned to two independent European cohorts
with LHON. In 30 trios from the European mainland,
two markers (DXS1219 and DXS8090) showed signif-
icant transmission disequilibrium in the XRC-TDT, and,
in 30 British trios, DXS1069 showed signiﬁcant trans-
mission disequilibrium in the XRC-TDT, conﬁrming
linkage and association with the same region of the X
chromosome (ﬁg. 1c). Differences in the strength of the
statistical association between adjacent markers in the
different populations is likely a reﬂection of different
marker allele frequencies in the different subgroups.
Figure 1 Mapping of the nuclear modiﬁer locus in Finnish pedigrees transmitting homoplasmic LHON mtDNA mutations. a, Human X
chromosome with the corresponding NPL scores for the initial linkage screen (maximum NPL score p 10.2). b, Fine mapping of the linked
locus, conﬁrming earlier ﬁndings and revealing a maximum NPL score of 47.5. c, XRC-TDT for informative markers in the Finnish, mainland
European, and British cohorts. As expected, the Finnish families show a large block of linkage and association corresponding to the linked
region. There is signiﬁcant transmission distortion for speciﬁc markers at the same locus for the British and mainland European cohorts, which
conﬁrms our initial ﬁndings and demonstrates the smaller block of LD present outside Finland. A black background indicates that the association
is nonsigniﬁcant; a yellow background indicates that it is signiﬁcant at the .05 level; and a yellow box without a value inside it indicates a
marker that is uninformative when the number of alleles is !4.
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Table 2
Logistic Regression Model of the Additive Effects of mtDNA
Haplotype and the DXS8090(166)-DXS1068(258) Haplotype in
Males Homoplasmic for 11778ArG, 14484TrC, and 14495ArG
Variables in the Equation P OR (95% CI)
Non mtDNA haplogroup J .043 2.45 (1.03–5.82)
DXS8090(166)-DXS1068(258) .001 33.84 (4.38–261.53)
Constant !.01 .02
NOTE.—As expected, the frequency of non-3460ArG haplogroup
J pedigrees (23%) was greater than the European average (found
to be 9%–14% in the European populations studied here). The ef-
fect of each genetic variable was approximately the same when
modeled independently as when both variables were included in
the same regression model. Modeling did not identify a signiﬁcant
direct interaction between mtDNA haplotype and DXS8090(166)-
DXS1068(258). x2 was greatest for the additive model ( ;2x p 35.68
). Together, these ﬁndings indicate that each genetic factorP ! .0001
that exerts its effect is independent and additive. Logistic regression
showed an increased risk of visual failure in non–haplogroup J ped-
igrees in this cohort. A formal study of the penetrance of LHON in
haplogroup J pedigrees versus non-J pedigrees had not been performed
previously.
Table 3
Logistic Regression Models of the Effects of mtDNA
Haplotype and the DXS8090(166)-DXS1068(258)
Haplotype in Males Homoplasmic for 11778ArG,
14484TrC, and 14495ArG
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
By comparing microsatellite allele frequencies in
146 European men, we identiﬁed the major high-risk
haplotype deﬁned by DXS8090 and DXS1068. Of
the 89 men affected with LHON, 37 (42%) had the
DXS8090(166)-DXS1068(258) haplotype, compared
with only 3 (5%) of 57 unaffected men (Fisher’s exact
P p .0001; odds ratio [OR] 12.81; 95% CI 3.72–
44.11).
The 3460ArG mutation is considered to be the most
severe molecular defect, with a consistently reduced
complex I activity (Howell et al. 1991), a less marked
sex bias (Newman et al. 1991; Johns et al. 1993), and
no association with the background mtDNA haplotype
(Man et al. 2004). We therefore thought that a nuclear-
mitochondrial interaction would be more prominent
in non-3460ArG pedigrees. In keeping with this, there
was no signiﬁcant increase in the risk of visual impair-
ment in 3460ArG males with the DXS8090(166)-
DXS1068(258) haplotype, but non-3460ArG males
were 135-fold more likely to develop visual failure if
they had the DXS8090(166)-DXS1068(258) haplotype
(table 1). In contrast to 3460ArG, both 11778GrA and
14484TrC are strongly associated with mtDNA hap-
logroup J (Man et al. 2004). We therefore used logistic
regression to determine whether the DXS8090(166)-
DXS1068(258) haplotype exerted its effect independent
of haplogroup J status, modeling the effect of the nuclear
or mtDNA haplotypes alone and through additive,
synergistic, and antagonistic interactions. An additive
interaction between DXS8090(166)-DXS1068(258)
and mtDNA haplogroup was the most compelling
model (tables 2 and 3). Non-3460ArG males who did
not harbor DXS8090(166)-DXS1068(258) and who
belonged to mtDNA haplogroup J had a 35.1% risk
of visual failure. The presence of DXS8090(166)-
DXS1068(258) or not belonging to mtDNA haplogroup
J was associated with a 58.9% risk of visual failure, but
100% of individuals who were both non-mtDNA hap-
logroup J and had DXS8090(166)-DXS1068(258) were
visually impaired ( ). The effect of the nuclearP ! .0001
haplotype (OR 33.84; 95% CI 4.38–261.53) was 110-
fold greater than that of the mtDNA haplotype (OR
2.45; 95% CI 1.03–5.82).
To conﬁrm our observations in males, we turned
our attention to non-3460ArG female subjects. Of
107 females, 20 (19.05%) were heterozygous for
DXS8090(166)-DXS1068(258). Given that LHON
was 97% penetrant in non-3460ArG males with
LHON who were hemizygous for DXS8090(166)-
DXS1068(258), we predicted that approximately four
females would be homozygous for DXS8090(166)-
DXS1068(258) and that most of them would also be
visually impaired. Five women were homozygous, four
of whom were also visually impaired, which supports a
recessive haploinsufﬁciency model. Molecular testing of
unaffected maternal relatives in known homoplasmic
pedigrees with LHON has been of limited clinical use
to date, conﬁrming the expected inheritance of the mu-
tation but not altering well-established recurrence risks.
Here, we show that identiﬁcation of DXS8090(166)-
DXS1068(258) in hemizygous males or homozygous
females greatly increases the chance of visual failure
occuring during life. This may be of use in prenatal di-
agnosis and predictive testing.
We also identiﬁed a second, less-frequent predisposing
haplotype in Europeans,DXS1068(258)-DXS8016(218),
present in 14.7% of males in this study. All males har-
boring this haplotype were affected (Fisher’s exact P !
), and the majority (74%) of these individuals also.0001
had DXS8090(166), indicating that this is a subgroup
of the common disease haplotype. It is possible that dial-
lelic mutation of microsatellites and recombination have
generated other, less-frequent high-risk marker haplo-
types that remain undetected in this study, contributing
to marker heterogeneity and confounding attempts to
map the locus. We therefore performed homozygosity
mapping with the 10K SNP microarray (Affymetrix) for
four unrelated women with visual failure due to the
11778ArG mutation who had more than three male
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Table 4
Grandparental Origin of X-Chromosomal Markers in
Males from 3-Generation Pedigrees with Homoplasmic
LHON mtDNA Mutations
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Figure 2 Homozygosity mapping with the 10K SNP Affymetrix
microarray for four unrelated women with visual failure due to a
homoplasmic LHON mutation. The legend is available in its entirety
in the online edition of The American Journal of Human Genetics.
offspring, all of whom were clinically affected. All four
women were homozygous for SNPs adjacent to the crit-
ical region, which pointed toward a small, common
shared haplotype block (ﬁg. 2). On the other hand, the
striking difference between the Finns and the other Eu-
ropean subjects points to allelic heterogeneity at the nu-
clear visual-loss susceptibility locus, and not just at
the ﬂanking markers. Of the affected Finnish men, 63%
had a high-risk haplotype deﬁned by DXS8090(168)-
DXS1069(262) ( ; OR 7.71; 95% CI 1.28–Pp .0259
46.37), found in only 3.7% of mainland Europeans in
this study. Different nuclear alleles may behave in subtly
different ways that are speciﬁc to particular LHON
mtDNA mutations or geographic/ethnic regions.
Epigenetic mechanisms provide an alternative expla-
nation for the reduced penetrance and sex bias in
LHON. Although two studies failed to ﬁnd skewed X
inactivation in the blood (Pegoraro et al. 1996) and oc-
ular tissue (Pegoraro et al. 2003) from women affected
with LHON, many imprinted disease genes do not show
X skewing (Renieri et al. 2003). In families with no
known disease, the failure to fully correct a maternal
imprint leads to the preferential transmission of grand-
paternal chromosomes to male offspring (Naumova et
al. 1998). The inheritance of a partially silenced grand-
paternal gene could explain the characteristic penetrance
of primary LHON mutations in males and could also
explain the further reduced penetrance in women when
it is superimposed on the normal female random inac-
tivation pattern. X-chromosomal imprinting has been
implicated in a number of common neurodevelopmental
diseases (Falls et al. 1999), resulting in “parent of origin”
effects. We therefore manually reconstructed the 3-gen-
eration X-chromosomal haplotypes in 52 males with
homoplasmic LHON mtDNA mutations. Overall, we
observed the same distortion of transmission of grand-
paternal alleles that is well described in control popu-
lations (proportion of grandpaternal alleles p 0.60;
95% CI 0.45–0.73; , for comparison with con-Pp .87
trol data of Naumova et al. [1998]). There was no dif-
ference in the frequency of grandpaternal alleles between
affected and unaffected male offspring (table 4) nor be-
tween affected and unaffected female offspring, which
suggests that imprinting is not the principal mechanism
underpinning the phenotypic variability seen in LHON.
In conclusion, we have identiﬁed a region of the X
chromosome containing a high-risk haplotype that ex-
plains the reduced penetrance and sex bias that char-
acterizes LHON in the majority of pedigrees. Clariﬁ-
cation of the underlying sequence variation is likely to
have broader implications for our understanding of nu-
clear-mitochondrial interactions in health and disease,
opening new avenues for therapeutic intervention.
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